Historical Stock Price
TRVN historical stock prices picture
Trevena (TRVN) has the following price history information. Looking back at TRVN historical stock prices for the last five trading days, on April 15, 2024, TRVN opened at $0.38, traded as high as $0.42 and as low as $0.38, and closed at $0.39. Trading volume was a total of 68.00K shares. On April 16, 2024, TRVN opened at $0.39, traded as high as $0.40 and as low as $0.37, and closed at $0.39. Trading volume was a total of 73.10K shares. On April 17, 2024, TRVN opened at $0.38, traded as high as $0.41 and as low as $0.37, and closed at $0.40. Trading volume was a total of 3.66M shares. On April 18, 2024, TRVN opened at $0.42, traded as high as $0.43 and as low as $0.36, and closed at $0.37. Trading volume was a total of 1.24M shares. On April 19, 2024, TRVN opened at $0.35, traded as high as $0.36 and as low as $0.32, and closed at $0.35. Trading volume was a total of 170.20K shares.

TRVN Historical Stock Prices By Date:

TRVN historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Trevena shares, starting with a $10,000 purchase of TRVN, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 04/22/2014
End date: 04/19/2024
Start price/share: $146.25
End price/share: $0.35
Dividends collected/share: $0.00
Total return: -99.76%
Average Annual Total Return: -45.28%
Starting investment: $10,000.00
Ending investment: $24.07
Years: 10.00
Date Open High Low Close Volume
04/15/2024 $0.38 $0.42 $0.38 $0.39 68.00K
04/16/2024 $0.39 $0.40 $0.37 $0.39 73.10K
04/17/2024 $0.38 $0.41 $0.37 $0.40 3.66M
04/18/2024 $0.42 $0.43 $0.36 $0.37 1.24M
04/19/2024 $0.35 $0.36 $0.32 $0.35 170.20K
Trevena is a biopharmaceutical company. Co.'s primary product, OLINVYK™ (oliceridine) injection, is an opioid agonist for use in adults for the management of acute pain severe enough to require an intravenous opioid analgesic and for whom alternative treatments are inadequate. Co.'s product candidates include: TRV250, which is a G-protein biased delta-opioid receptor agonist as a compound with a mechanism for the treatment of acute migraine; TRV045, which is Co.'s sphingosine-1-phosphate receptor modulator that may provide a non-opioid approach to managing chronic pain; as well as TRV734, a new chemical entity targeting the same mechanism of action at the mu opioid receptor as OLINVYK.
Date Close
04/15/2024$0.39
04/16/2024$0.39
04/17/2024$0.40
04/18/2024$0.37
04/19/2024$0.35
TRVN is categorized under the Healthcare sector; below are some other companies in the same sector:

TRXC Historical Stock Prices
TSPT Historical Stock Prices
TSRO Historical Stock Prices
TSRX Historical Stock Prices
TTHI Historical Stock Prices
TTNP Historical Stock Prices
TTOO Historical Stock Prices
TTPH Historical Stock Prices
TVTY Historical Stock Prices
TXMD Historical Stock Prices

Also explore: TRVN shares outstanding history

Email EnvelopeFree TRVN Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts


TRVN Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.